Hematological Changes Following Low Dose Radiation Therapy and Comparison to Current Standard of Care Cancer Treatments
Cancer is the second leading cause of mortality worldwide accounting for almost 10 million deaths in 2020. Current standard of care treatment varies depending on the type and stage of disease, but commonly includes surgery, chemotherapy, and/or radiation therapy. There is evidence that whole- and ha...
Guardado en:
Autores principales: | Alexandra Jameus, Allison E. Kennedy, Christopher Thome |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff8a5fce13ce400c83b20d0a2d44f999 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of Low-Dose Gamma Radiation and Lipoic Acid on High- Radiation-Dose Induced Rat Brain Injuries
por: Nahed Abdel-Aziz, et al.
Publicado: (2021) -
Immunological and hematological outcomes following protracted low dose/low dose rate ionizing radiation and simulated microgravity
por: Amber M. Paul, et al.
Publicado: (2021) -
Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs
por: Helen Humphries, et al.
Publicado: (2021) -
Rhinoplasty Pre-Surgery Models by Using Low-Dose Computed Tomography, Magnetic Resonance Imaging, and 3D Printing
por: Dario Baldi, et al.
Publicado: (2021) -
Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Letter]
por: Hendrikx JJMA, et al.
Publicado: (2020)